[
  {
    "title": "Eli Lilly Alzheimer\u2019s therapy set for June FDA AdCom meeting",
    "published": 1715071260,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 221.97999572753906,
      "2024-05-07T14:30:00+00:00": 219.61000061035156,
      "2024-05-07T15:30:00+00:00": 216.57000732421875,
      "2024-05-07T16:30:00+00:00": 217.2899932861328,
      "2024-05-07T17:30:00+00:00": 217.61000061035156,
      "2024-05-07T18:30:00+00:00": 218.27499389648438,
      "2024-05-07T19:30:00+00:00": 218.83999633789062
    },
    "sentiment": 0.9474264979362488
  },
  {
    "title": "Morgan Stanley\u2019s Top 15 Stock Picks for 2024",
    "published": 1714832848,
    "day_prices": {},
    "sentiment": 0.9358375072479248
  },
  {
    "title": "Biogen price target raised by $3 at HSBC, here's why",
    "published": 1714720140,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 215.3000030517578,
      "2024-05-03T14:30:00+00:00": 214.3000030517578,
      "2024-05-03T15:30:00+00:00": 214.77000427246094,
      "2024-05-03T16:30:00+00:00": 216.2100067138672,
      "2024-05-03T17:30:00+00:00": 215.3699951171875,
      "2024-05-03T18:30:00+00:00": 216.10499572753906,
      "2024-05-03T19:30:00+00:00": 217.55499267578125
    },
    "sentiment": 0.7540046572685242
  },
  {
    "title": "Biogen Inc. stock underperforms Thursday when compared to competitors",
    "published": 1714622580,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 217.99000549316406,
      "2024-05-02T14:30:00+00:00": 215.5500030517578,
      "2024-05-02T15:30:00+00:00": 214.80999755859375,
      "2024-05-02T16:30:00+00:00": 215.75999450683594,
      "2024-05-02T17:30:00+00:00": 214.6199951171875,
      "2024-05-02T18:30:00+00:00": 214.27499389648438,
      "2024-05-02T19:30:00+00:00": 214.1199951171875
    },
    "sentiment": 0.9049740433692932
  },
  {
    "title": "AbCellera partners with PE firms to develop antibody drugs, company creation",
    "published": 1714560540,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 215.55999755859375,
      "2024-05-01T14:30:00+00:00": 215.91000366210938,
      "2024-05-01T15:30:00+00:00": 216.41000366210938,
      "2024-05-01T16:30:00+00:00": 216.88499450683594,
      "2024-05-01T17:30:00+00:00": 215.80999755859375,
      "2024-05-01T18:30:00+00:00": 215.29249572753906,
      "2024-05-01T19:30:00+00:00": 218.02000427246094
    },
    "sentiment": 0.5097097754478455
  },
  {
    "title": "Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector",
    "published": 1715789520,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.887531042098999
  },
  {
    "title": "Eisai sets new revenue target for Alzheimer\u2019s drug Leqembi",
    "published": 1715775900,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.5616592764854431
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: scPharmaceuticals (SCPH), Optinose (OPTN)",
    "published": 1715760120,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.47826024889945984
  },
  {
    "title": "Biogen partner Eisai begins FDA submissions for injectable Alzheimer\u2019s therapy",
    "published": 1715755620,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.7766045928001404
  },
  {
    "title": "UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA",
    "published": 1715746627,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.7023892998695374
  },
  {
    "title": "Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI\u00ae (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer\u2019s Disease Under the Fast Track Status",
    "published": 1715729580,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 226.10000610351562,
      "2024-05-14T14:30:00+00:00": 222.5800018310547,
      "2024-05-14T15:30:00+00:00": 222.69000244140625,
      "2024-05-14T16:30:00+00:00": 224.0,
      "2024-05-14T17:30:00+00:00": 224.36000061035156,
      "2024-05-14T18:30:00+00:00": 225.55999755859375,
      "2024-05-14T19:30:00+00:00": 226.19000244140625
    },
    "sentiment": 0.6995294094085693
  },
  {
    "title": "Eisai/Biogen initiate FDA BLA for LEQEMBI",
    "published": 1715669640,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 226.10000610351562,
      "2024-05-14T14:30:00+00:00": 222.5800018310547,
      "2024-05-14T15:30:00+00:00": 222.69000244140625,
      "2024-05-14T16:30:00+00:00": 224.0,
      "2024-05-14T17:30:00+00:00": 224.36000061035156,
      "2024-05-14T18:30:00+00:00": 225.55999755859375,
      "2024-05-14T19:30:00+00:00": 226.19000244140625
    },
    "sentiment": 0.8543344140052795
  },
  {
    "title": "Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank",
    "published": 1715588220,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 223.0,
      "2024-05-13T14:30:00+00:00": 222.75999450683594,
      "2024-05-13T15:30:00+00:00": 223.6699981689453,
      "2024-05-13T16:30:00+00:00": 224.22500610351562,
      "2024-05-13T17:30:00+00:00": 224.0850067138672,
      "2024-05-13T18:30:00+00:00": 224.6999969482422,
      "2024-05-13T19:30:00+00:00": 224.24000549316406
    },
    "sentiment": 0.9074742197990417
  },
  {
    "title": "The 3 Most Undervalued Pharma Stocks to Buy in May 2024",
    "published": 1715250600,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 220.6699981689453,
      "2024-05-09T14:30:00+00:00": 220.92999267578125,
      "2024-05-09T15:30:00+00:00": 220.3800048828125,
      "2024-05-09T16:30:00+00:00": 220.77000427246094,
      "2024-05-09T17:30:00+00:00": 221.8699951171875,
      "2024-05-09T18:30:00+00:00": 221.72999572753906,
      "2024-05-09T19:30:00+00:00": 221.85499572753906
    },
    "sentiment": 0.7523890137672424
  },
  {
    "title": "Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors",
    "published": 1716492785,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.6833759546279907
  },
  {
    "title": "DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen",
    "published": 1716483427,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.864453911781311
  },
  {
    "title": "Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline",
    "published": 1716473160,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.5496787428855896
  },
  {
    "title": "Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences",
    "published": 1716462453,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9284027218818665
  },
  {
    "title": "BIIB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
    "published": 1716445925,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.47277310490608215
  },
  {
    "title": "Buy Rating Affirmed for Biogen on Strategic Acquisition and Promising Pipeline",
    "published": 1716444960,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9363638162612915
  },
  {
    "title": "Biogen\u2019s Buy Rating Bolstered by Strategic Acquisition and Promising Pipeline Expansion",
    "published": 1716441960,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.952258825302124
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA) and Biogen (BIIB)",
    "published": 1716433380,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9072046279907227
  },
  {
    "title": "Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers - BIIB",
    "published": 1716406267,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5583438873291016
  },
  {
    "title": "Biogen acquiring HI-Bio in increased immunology focus, says William Blair",
    "published": 1716377460,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.939632773399353
  },
  {
    "title": "Biogen, looking to diversify, acquires immune drugmaker HI-Bio for $1.15B",
    "published": 1716376740,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.815977931022644
  },
  {
    "title": "Biogen acquisition has positive read for IGM Biosciences, says RBC Capital",
    "published": 1716374760,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.94495689868927
  },
  {
    "title": "Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings)",
    "published": 1716368520,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.7913380861282349
  },
  {
    "title": "Biogen swoops for Human Immunology Biosciences in USD1.8 billion deal",
    "published": 1716366300,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5264385938644409
  },
  {
    "title": "Biogen inks $1.8B deal to acquire immune drug developer HI-Bio",
    "published": 1716364080,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5526329874992371
  },
  {
    "title": "Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront",
    "published": 1716362520,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.9204524755477905
  },
  {
    "title": "Why Biogen Inc. (BIIB) is a Top Momentum Stock for the Long-Term",
    "published": 1716299411,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 229.2899932861328,
      "2024-05-21T14:30:00+00:00": 227.6199951171875,
      "2024-05-21T15:30:00+00:00": 226.5800018310547,
      "2024-05-21T16:30:00+00:00": 226.83999633789062,
      "2024-05-21T17:30:00+00:00": 226.26499938964844,
      "2024-05-21T18:30:00+00:00": 226.9149932861328,
      "2024-05-21T19:30:00+00:00": 227.44000244140625
    },
    "sentiment": 0.8405464291572571
  },
  {
    "title": "Larimar stock rallies 24% on FDA removal of partial clinical hold",
    "published": 1716182340,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 230.7100067138672,
      "2024-05-20T14:30:00+00:00": 230.6699981689453,
      "2024-05-20T15:30:00+00:00": 230.14500427246094,
      "2024-05-20T16:30:00+00:00": 231.26499938964844,
      "2024-05-20T17:30:00+00:00": 232.4199981689453,
      "2024-05-20T18:30:00+00:00": 231.05999755859375,
      "2024-05-20T19:30:00+00:00": 231.11000061035156
    },
    "sentiment": 0.8574684858322144
  },
  {
    "title": "Ionis (IONS), Biogen Down on Ending Development of ALS Drug",
    "published": 1715955000,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 229.02099609375,
      "2024-05-17T14:30:00+00:00": 227.48500061035156,
      "2024-05-17T15:30:00+00:00": 228.66000366210938,
      "2024-05-17T16:30:00+00:00": 230.63999938964844,
      "2024-05-17T17:30:00+00:00": 229.52000427246094,
      "2024-05-17T18:30:00+00:00": 229.49000549316406,
      "2024-05-17T19:30:00+00:00": 229.9550018310547
    },
    "sentiment": 0.9018823504447937
  },
  {
    "title": "Biogen Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "published": 1715918520,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 229.02099609375,
      "2024-05-17T14:30:00+00:00": 227.48500061035156,
      "2024-05-17T15:30:00+00:00": 228.66000366210938,
      "2024-05-17T16:30:00+00:00": 230.63999938964844,
      "2024-05-17T17:30:00+00:00": 229.52000427246094,
      "2024-05-17T18:30:00+00:00": 229.49000549316406,
      "2024-05-17T19:30:00+00:00": 229.9550018310547
    },
    "sentiment": 0.7750614881515503
  },
  {
    "title": "Biogen to halt development of ALS, Angelman Syndrome drugs",
    "published": 1715869860,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.6543722152709961
  },
  {
    "title": "Biogen, Ionis shelve ALS drug following study failure",
    "published": 1715861100,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.8339107036590576
  },
  {
    "title": "Biogen says won't exercise option to license and lead development of BIIB121",
    "published": 1715859480,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.9310190081596375
  },
  {
    "title": "Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis",
    "published": 1715859000,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.6615080833435059
  },
  {
    "title": "Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status",
    "published": 1715854911,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.685386598110199
  },
  {
    "title": "Biogen (BIIB) Receives a Buy from Truist Financial",
    "published": 1715841420,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.5580300092697144
  },
  {
    "title": "Biogen: A Balanced View Amidst Setbacks and Alzheimer\u2019s Drug Potential",
    "published": 1715838960,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.7848695516586304
  },
  {
    "title": "Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder",
    "published": 1717172709,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.6018654704093933
  },
  {
    "title": "Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?",
    "published": 1717169509,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.9710344076156616
  },
  {
    "title": "How To Invest: Using Shorter-Term Moving Averages To Trade Stocks",
    "published": 1717156855,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.9395756125450134
  },
  {
    "title": "Biogen: Brussels grants marketing authorization for Charcot disease",
    "published": 1717149620,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.6856043338775635
  },
  {
    "title": "Biogen Receives European Commission Approval for QALSODY\u00ae\u00a0(tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS",
    "published": 1717102260,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.893140971660614
  },
  {
    "title": "Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB",
    "published": 1717088469,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.9182083010673523
  },
  {
    "title": "Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?",
    "published": 1717072242,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.769070029258728
  },
  {
    "title": "Analyst Favorites With Strong Buyback Activity: Biogen Ranks As a Top Pick",
    "published": 1717071420,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.9347348809242249
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)",
    "published": 1717063260,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.7460070848464966
  },
  {
    "title": "BIIB Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!",
    "published": 1717041668,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.8682867884635925
  },
  {
    "title": "Gain Therapeutics: Phase 1 Readout Awaits For Parkinson's Drug With Great Potential",
    "published": 1717006511,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 216.11000061035156,
      "2024-05-29T14:30:00+00:00": 211.22999572753906,
      "2024-05-29T15:30:00+00:00": 212.60499572753906,
      "2024-05-29T16:30:00+00:00": 213.44000244140625,
      "2024-05-29T17:30:00+00:00": 214.9149932861328,
      "2024-05-29T18:30:00+00:00": 213.97999572753906,
      "2024-05-29T19:30:00+00:00": 214.9199981689453
    },
    "sentiment": 0.9285709857940674
  },
  {
    "title": "Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN",
    "published": 1716992830,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 216.11000061035156,
      "2024-05-29T14:30:00+00:00": 211.22999572753906,
      "2024-05-29T15:30:00+00:00": 212.60499572753906,
      "2024-05-29T16:30:00+00:00": 213.44000244140625,
      "2024-05-29T17:30:00+00:00": 214.9149932861328,
      "2024-05-29T18:30:00+00:00": 213.97999572753906,
      "2024-05-29T19:30:00+00:00": 214.9199981689453
    },
    "sentiment": 0.939631998538971
  },
  {
    "title": "Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB",
    "published": 1716928565,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.8303357362747192
  },
  {
    "title": "Biogen reports Leqembi approved for treatment of Alzheimer's in South Korea",
    "published": 1716877200,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.8884419798851013
  },
  {
    "title": "\"LEQEMBI\" Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea",
    "published": 1716870787,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.5820940732955933
  },
  {
    "title": "South Korea\u2019s MFDS approves Eisai-Biogen\u2019s LEQEMBI for Alzheimer\u2019s",
    "published": 1716806102,
    "day_prices": {},
    "sentiment": 0.7195767164230347
  },
  {
    "title": "IN BRIEF: Biogen's Alzheimer's treatment wins South Korean approval",
    "published": 1716776340,
    "day_prices": {},
    "sentiment": 0.9092076420783997
  },
  {
    "title": "Parnassus Value Equity Fund Q1 2024 Investment Commentary",
    "published": 1716701400,
    "day_prices": {},
    "sentiment": 0.9324530959129333
  },
  {
    "title": "Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?",
    "published": 1716564665,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.8901647329330444
  },
  {
    "title": "The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics",
    "published": 1716557880,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.9402798414230347
  },
  {
    "title": "Strategic Acquisitions and Clinical Catalysts Bolster Biogen\u2019s Buy Rating",
    "published": 1716554940,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.9542121887207031
  },
  {
    "title": "Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB)",
    "published": 1719597668,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 229.5,
      "2024-06-28T14:30:00+00:00": 233.99000549316406,
      "2024-06-28T15:30:00+00:00": 231.14999389648438,
      "2024-06-28T16:30:00+00:00": 229.64500427246094,
      "2024-06-28T17:30:00+00:00": 230.24000549316406,
      "2024-06-28T18:30:00+00:00": 229.9199981689453,
      "2024-06-28T19:30:00+00:00": 229.4199981689453
    },
    "sentiment": 0.6538522839546204
  },
  {
    "title": "Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors Limiting Growth",
    "published": 1719568920,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 229.5,
      "2024-06-28T14:30:00+00:00": 233.99000549316406,
      "2024-06-28T15:30:00+00:00": 231.14999389648438,
      "2024-06-28T16:30:00+00:00": 229.64500427246094,
      "2024-06-28T17:30:00+00:00": 230.24000549316406,
      "2024-06-28T18:30:00+00:00": 229.9199981689453,
      "2024-06-28T19:30:00+00:00": 229.4199981689453
    },
    "sentiment": 0.6134134531021118
  },
  {
    "title": "Biogen, Eisai launch Alzheimer's drug Leqembi in China",
    "published": 1719551940,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 229.5,
      "2024-06-28T14:30:00+00:00": 233.99000549316406,
      "2024-06-28T15:30:00+00:00": 231.14999389648438,
      "2024-06-28T16:30:00+00:00": 229.64500427246094,
      "2024-06-28T17:30:00+00:00": 230.24000549316406,
      "2024-06-28T18:30:00+00:00": 229.9199981689453,
      "2024-06-28T19:30:00+00:00": 229.4199981689453
    },
    "sentiment": 0.7916646599769592
  },
  {
    "title": "IN BRIEF: Biogen's Leqembi launches in China to treat Alzheimer's",
    "published": 1719538260,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 229.5,
      "2024-06-28T14:30:00+00:00": 233.99000549316406,
      "2024-06-28T15:30:00+00:00": 231.14999389648438,
      "2024-06-28T16:30:00+00:00": 229.64500427246094,
      "2024-06-28T17:30:00+00:00": 230.24000549316406,
      "2024-06-28T18:30:00+00:00": 229.9199981689453,
      "2024-06-28T19:30:00+00:00": 229.4199981689453
    },
    "sentiment": 0.7111817002296448
  },
  {
    "title": "\u201cLEQEMBI\u00ae\u201d (Lecanemab) for the Treatment of Alzheimer\u2019s Disease Launched in China",
    "published": 1719531540,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 223.42999267578125,
      "2024-06-27T14:30:00+00:00": 228.16000366210938,
      "2024-06-27T15:30:00+00:00": 230.0800018310547,
      "2024-06-27T16:30:00+00:00": 227.9600067138672,
      "2024-06-27T17:30:00+00:00": 227.3699951171875,
      "2024-06-27T18:30:00+00:00": 227.22000122070312,
      "2024-06-27T19:30:00+00:00": 228.58999633789062
    },
    "sentiment": 0.5216046571731567
  },
  {
    "title": "August 9th Options Now Available For Biogen (BIIB)",
    "published": 1719485460,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 223.42999267578125,
      "2024-06-27T14:30:00+00:00": 228.16000366210938,
      "2024-06-27T15:30:00+00:00": 230.0800018310547,
      "2024-06-27T16:30:00+00:00": 227.9600067138672,
      "2024-06-27T17:30:00+00:00": 227.3699951171875,
      "2024-06-27T18:30:00+00:00": 227.22000122070312,
      "2024-06-27T19:30:00+00:00": 228.58999633789062
    },
    "sentiment": 0.9457303881645203
  },
  {
    "title": "Biogen's Lecanemab launched in China to treat Alzheimer's Disease Use symbol  Eisai",
    "published": 1719470940,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 223.42999267578125,
      "2024-06-27T14:30:00+00:00": 228.16000366210938,
      "2024-06-27T15:30:00+00:00": 230.0800018310547,
      "2024-06-27T16:30:00+00:00": 227.9600067138672,
      "2024-06-27T17:30:00+00:00": 227.3699951171875,
      "2024-06-27T18:30:00+00:00": 227.22000122070312,
      "2024-06-27T19:30:00+00:00": 228.58999633789062
    },
    "sentiment": 0.5142185688018799
  },
  {
    "title": "BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit",
    "published": 1719403272,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 221.7899932861328,
      "2024-06-26T14:30:00+00:00": 224.33999633789062,
      "2024-06-26T15:30:00+00:00": 223.92999267578125,
      "2024-06-26T16:30:00+00:00": 222.88999938964844,
      "2024-06-26T17:30:00+00:00": 222.5500030517578,
      "2024-06-26T18:30:00+00:00": 222.5800018310547,
      "2024-06-26T19:30:00+00:00": 223.35499572753906
    },
    "sentiment": 0.8755634427070618
  },
  {
    "title": "DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen",
    "published": 1719394568,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 221.7899932861328,
      "2024-06-26T14:30:00+00:00": 224.33999633789062,
      "2024-06-26T15:30:00+00:00": 223.92999267578125,
      "2024-06-26T16:30:00+00:00": 222.88999938964844,
      "2024-06-26T17:30:00+00:00": 222.5500030517578,
      "2024-06-26T18:30:00+00:00": 222.5800018310547,
      "2024-06-26T19:30:00+00:00": 223.35499572753906
    },
    "sentiment": 0.8384593725204468
  },
  {
    "title": "Shareholders of Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB",
    "published": 1719380783,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 221.7899932861328,
      "2024-06-26T14:30:00+00:00": 224.33999633789062,
      "2024-06-26T15:30:00+00:00": 223.92999267578125,
      "2024-06-26T16:30:00+00:00": 222.88999938964844,
      "2024-06-26T17:30:00+00:00": 222.5500030517578,
      "2024-06-26T18:30:00+00:00": 222.5800018310547,
      "2024-06-26T19:30:00+00:00": 223.35499572753906
    },
    "sentiment": 0.9434400200843811
  },
  {
    "title": "RBC believes Leqembi on track for EU approval after speaking to Biogen",
    "published": 1719368340,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 221.7899932861328,
      "2024-06-26T14:30:00+00:00": 224.33999633789062,
      "2024-06-26T15:30:00+00:00": 223.92999267578125,
      "2024-06-26T16:30:00+00:00": 222.88999938964844,
      "2024-06-26T17:30:00+00:00": 222.5500030517578,
      "2024-06-26T18:30:00+00:00": 222.5800018310547,
      "2024-06-26T19:30:00+00:00": 223.35499572753906
    },
    "sentiment": 0.8971413373947144
  },
  {
    "title": "Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact The Gross Law Firm",
    "published": 1719294380,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 225.11000061035156,
      "2024-06-25T14:30:00+00:00": 225.85499572753906,
      "2024-06-25T15:30:00+00:00": 225.4199981689453,
      "2024-06-25T16:30:00+00:00": 224.1199951171875,
      "2024-06-25T17:30:00+00:00": 224.14990234375,
      "2024-06-25T18:30:00+00:00": 224.08999633789062,
      "2024-06-25T19:30:00+00:00": 223.1300048828125
    },
    "sentiment": 0.8599523305892944
  },
  {
    "title": "Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?",
    "published": 1719237012,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 225.74000549316406,
      "2024-06-24T14:30:00+00:00": 226.02000427246094,
      "2024-06-24T15:30:00+00:00": 226.9499969482422,
      "2024-06-24T16:30:00+00:00": 227.24000549316406,
      "2024-06-24T17:30:00+00:00": 227.01499938964844,
      "2024-06-24T18:30:00+00:00": 227.1699981689453,
      "2024-06-24T19:30:00+00:00": 226.4600067138672
    },
    "sentiment": 0.9114817380905151
  },
  {
    "title": "Biogen announces Tofidence biosimilar approved in European Union",
    "published": 1719212340,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 225.74000549316406,
      "2024-06-24T14:30:00+00:00": 226.02000427246094,
      "2024-06-24T15:30:00+00:00": 226.9499969482422,
      "2024-06-24T16:30:00+00:00": 227.24000549316406,
      "2024-06-24T17:30:00+00:00": 227.01499938964844,
      "2024-06-24T18:30:00+00:00": 227.1699981689453,
      "2024-06-24T19:30:00+00:00": 226.4600067138672
    },
    "sentiment": 0.7500031590461731
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Sharecare (SHCR), Amylyx Pharmaceuticals Inc (AMLX) and Biogen (BIIB)",
    "published": 1719206520,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 225.74000549316406,
      "2024-06-24T14:30:00+00:00": 226.02000427246094,
      "2024-06-24T15:30:00+00:00": 226.9499969482422,
      "2024-06-24T16:30:00+00:00": 227.24000549316406,
      "2024-06-24T17:30:00+00:00": 227.01499938964844,
      "2024-06-24T18:30:00+00:00": 227.1699981689453,
      "2024-06-24T19:30:00+00:00": 226.4600067138672
    },
    "sentiment": 0.815157949924469
  },
  {
    "title": "Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP",
    "published": 1718974868,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 227.35000610351562,
      "2024-06-21T14:30:00+00:00": 224.59669494628906,
      "2024-06-21T15:30:00+00:00": 222.80999755859375,
      "2024-06-21T16:30:00+00:00": 222.75999450683594,
      "2024-06-21T17:30:00+00:00": 223.1649932861328,
      "2024-06-21T18:30:00+00:00": 223.5500030517578,
      "2024-06-21T19:30:00+00:00": 223.1699981689453
    },
    "sentiment": 0.8269188404083252
  },
  {
    "title": "Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIB",
    "published": 1718862381,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 220.94000244140625,
      "2024-06-20T14:30:00+00:00": 222.97999572753906,
      "2024-06-20T15:30:00+00:00": 224.02000427246094,
      "2024-06-20T16:30:00+00:00": 225.27000427246094,
      "2024-06-20T17:30:00+00:00": 225.75,
      "2024-06-20T18:30:00+00:00": 225.88999938964844,
      "2024-06-20T19:30:00+00:00": 225.82000732421875
    },
    "sentiment": 0.9403579831123352
  },
  {
    "title": "Eli Lilly: The Party Is Probably Nearing The End",
    "published": 1718800239,
    "day_prices": {},
    "sentiment": 0.8810205459594727
  },
  {
    "title": "Eli Lilly And Alzheimer's Disease: The Paucity Of Progress",
    "published": 1718647094,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 229.94000244140625,
      "2024-06-17T14:30:00+00:00": 228.19000244140625,
      "2024-06-17T15:30:00+00:00": 227.0800018310547,
      "2024-06-17T16:30:00+00:00": 227.80499267578125,
      "2024-06-17T17:30:00+00:00": 226.97999572753906,
      "2024-06-17T18:30:00+00:00": 227.35000610351562,
      "2024-06-17T19:30:00+00:00": 226.69000244140625
    },
    "sentiment": 0.8734054565429688
  },
  {
    "title": "Two Is Better Than One in the Alzheimer\u2019s Market",
    "published": 1718622000,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 229.94000244140625,
      "2024-06-17T14:30:00+00:00": 228.19000244140625,
      "2024-06-17T15:30:00+00:00": 227.0800018310547,
      "2024-06-17T16:30:00+00:00": 227.80499267578125,
      "2024-06-17T17:30:00+00:00": 226.97999572753906,
      "2024-06-17T18:30:00+00:00": 227.35000610351562,
      "2024-06-17T19:30:00+00:00": 226.69000244140625
    },
    "sentiment": 0.8399910926818848
  },
  {
    "title": "Shareholders of Biogen Inc. Should Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIB",
    "published": 1718603186,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 229.94000244140625,
      "2024-06-17T14:30:00+00:00": 228.19000244140625,
      "2024-06-17T15:30:00+00:00": 227.0800018310547,
      "2024-06-17T16:30:00+00:00": 227.80499267578125,
      "2024-06-17T17:30:00+00:00": 226.97999572753906,
      "2024-06-17T18:30:00+00:00": 227.35000610351562,
      "2024-06-17T19:30:00+00:00": 226.69000244140625
    },
    "sentiment": 0.9415503144264221
  },
  {
    "title": "The 3 Best Healthcare Stocks to Buy in June 2024",
    "published": 1718420820,
    "day_prices": {},
    "sentiment": 0.8791823983192444
  },
  {
    "title": "Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)",
    "published": 1718378460,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 232.55999755859375,
      "2024-06-14T14:30:00+00:00": 231.24000549316406,
      "2024-06-14T15:30:00+00:00": 231.50999450683594,
      "2024-06-14T16:30:00+00:00": 230.74000549316406,
      "2024-06-14T17:30:00+00:00": 231.0050048828125,
      "2024-06-14T18:30:00+00:00": 231.50999450683594,
      "2024-06-14T19:30:00+00:00": 232.07000732421875
    },
    "sentiment": 0.8855574727058411
  },
  {
    "title": "Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB",
    "published": 1718343984,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 232.55999755859375,
      "2024-06-14T14:30:00+00:00": 231.24000549316406,
      "2024-06-14T15:30:00+00:00": 231.50999450683594,
      "2024-06-14T16:30:00+00:00": 230.74000549316406,
      "2024-06-14T17:30:00+00:00": 231.0050048828125,
      "2024-06-14T18:30:00+00:00": 231.50999450683594,
      "2024-06-14T19:30:00+00:00": 232.07000732421875
    },
    "sentiment": 0.903630793094635
  },
  {
    "title": "Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab",
    "published": 1718202120,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 227.6199951171875,
      "2024-06-12T14:30:00+00:00": 228.77499389648438,
      "2024-06-12T15:30:00+00:00": 231.82000732421875,
      "2024-06-12T16:30:00+00:00": 230.9149932861328,
      "2024-06-12T17:30:00+00:00": 230.2899932861328,
      "2024-06-12T18:30:00+00:00": 229.72000122070312,
      "2024-06-12T19:30:00+00:00": 229.33999633789062
    },
    "sentiment": 0.7397111058235168
  },
  {
    "title": "Biogen executive plays down looming competition for its Alzheimer's drug",
    "published": 1718198318,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 227.6199951171875,
      "2024-06-12T14:30:00+00:00": 228.77499389648438,
      "2024-06-12T15:30:00+00:00": 231.82000732421875,
      "2024-06-12T16:30:00+00:00": 230.9149932861328,
      "2024-06-12T17:30:00+00:00": 230.2899932861328,
      "2024-06-12T18:30:00+00:00": 229.72000122070312,
      "2024-06-12T19:30:00+00:00": 229.33999633789062
    },
    "sentiment": 0.915172278881073
  },
  {
    "title": "Scotiabank Sticks to Their Buy Rating for Biogen (BIIB)",
    "published": 1718173740,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 227.6199951171875,
      "2024-06-12T14:30:00+00:00": 228.77499389648438,
      "2024-06-12T15:30:00+00:00": 231.82000732421875,
      "2024-06-12T16:30:00+00:00": 230.9149932861328,
      "2024-06-12T17:30:00+00:00": 230.2899932861328,
      "2024-06-12T18:30:00+00:00": 229.72000122070312,
      "2024-06-12T19:30:00+00:00": 229.33999633789062
    },
    "sentiment": 0.8032985329627991
  },
  {
    "title": "Delta Flight Products (DFP) and Biogen collaborate on accessibility",
    "published": 1718163129,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 227.6199951171875,
      "2024-06-12T14:30:00+00:00": 228.77499389648438,
      "2024-06-12T15:30:00+00:00": 231.82000732421875,
      "2024-06-12T16:30:00+00:00": 230.9149932861328,
      "2024-06-12T17:30:00+00:00": 230.2899932861328,
      "2024-06-12T18:30:00+00:00": 229.72000122070312,
      "2024-06-12T19:30:00+00:00": 229.33999633789062
    },
    "sentiment": 0.8610954880714417
  },
  {
    "title": "Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower",
    "published": 1718136455,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 225.8800048828125,
      "2024-06-11T14:30:00+00:00": 226.96499633789062,
      "2024-06-11T15:30:00+00:00": 226.6999969482422,
      "2024-06-11T16:30:00+00:00": 227.03990173339844,
      "2024-06-11T17:30:00+00:00": 226.39999389648438,
      "2024-06-11T18:30:00+00:00": 227.97999572753906,
      "2024-06-11T19:30:00+00:00": 227.47000122070312
    },
    "sentiment": 0.8645509481430054
  },
  {
    "title": "Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win",
    "published": 1718122835,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 225.8800048828125,
      "2024-06-11T14:30:00+00:00": 226.96499633789062,
      "2024-06-11T15:30:00+00:00": 226.6999969482422,
      "2024-06-11T16:30:00+00:00": 227.03990173339844,
      "2024-06-11T17:30:00+00:00": 226.39999389648438,
      "2024-06-11T18:30:00+00:00": 227.97999572753906,
      "2024-06-11T19:30:00+00:00": 227.47000122070312
    },
    "sentiment": 0.9623889923095703
  },
  {
    "title": "Donanemab approval would fuel growth of amyloid-blocking Alzheimer\u2019s drugs, analysts say",
    "published": 1718108520,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 225.8800048828125,
      "2024-06-11T14:30:00+00:00": 226.96499633789062,
      "2024-06-11T15:30:00+00:00": 226.6999969482422,
      "2024-06-11T16:30:00+00:00": 227.03990173339844,
      "2024-06-11T17:30:00+00:00": 226.39999389648438,
      "2024-06-11T18:30:00+00:00": 227.97999572753906,
      "2024-06-11T19:30:00+00:00": 227.47000122070312
    },
    "sentiment": 0.7956247329711914
  },
  {
    "title": "Eli Lilly Stock (LLY) Gained on FDA Panel Approval",
    "published": 1718077680,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 225.8800048828125,
      "2024-06-11T14:30:00+00:00": 226.96499633789062,
      "2024-06-11T15:30:00+00:00": 226.6999969482422,
      "2024-06-11T16:30:00+00:00": 227.03990173339844,
      "2024-06-11T17:30:00+00:00": 226.39999389648438,
      "2024-06-11T18:30:00+00:00": 227.97999572753906,
      "2024-06-11T19:30:00+00:00": 227.47000122070312
    },
    "sentiment": 0.9434215426445007
  },
  {
    "title": "FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug",
    "published": 1718054225,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 224.52000427246094,
      "2024-06-10T14:30:00+00:00": 228.1199951171875,
      "2024-06-10T15:30:00+00:00": 227.13499450683594,
      "2024-06-10T16:30:00+00:00": 226.5850067138672,
      "2024-06-10T17:30:00+00:00": 227.39999389648438,
      "2024-06-10T18:30:00+00:00": 227.25999450683594,
      "2024-06-10T19:30:00+00:00": 226.27000427246094
    },
    "sentiment": 0.5761475563049316
  },
  {
    "title": "Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance",
    "published": 1718027640,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 224.52000427246094,
      "2024-06-10T14:30:00+00:00": 228.1199951171875,
      "2024-06-10T15:30:00+00:00": 227.13499450683594,
      "2024-06-10T16:30:00+00:00": 226.5850067138672,
      "2024-06-10T17:30:00+00:00": 227.39999389648438,
      "2024-06-10T18:30:00+00:00": 227.25999450683594,
      "2024-06-10T19:30:00+00:00": 226.27000427246094
    },
    "sentiment": 0.844098687171936
  },
  {
    "title": "Biogen says FDA accepts application for Leqembi to treat Alzheimer's",
    "published": 1718001720,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 224.52000427246094,
      "2024-06-10T14:30:00+00:00": 228.1199951171875,
      "2024-06-10T15:30:00+00:00": 227.13499450683594,
      "2024-06-10T16:30:00+00:00": 226.5850067138672,
      "2024-06-10T17:30:00+00:00": 227.39999389648438,
      "2024-06-10T18:30:00+00:00": 227.25999450683594,
      "2024-06-10T19:30:00+00:00": 226.27000427246094
    },
    "sentiment": 0.801848292350769
  },
  {
    "title": "Buy Rating for Biogen Justified by Competitive Edge and FDA Insights on Safety Profiles",
    "published": 1717994160,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 224.52000427246094,
      "2024-06-10T14:30:00+00:00": 228.1199951171875,
      "2024-06-10T15:30:00+00:00": 227.13499450683594,
      "2024-06-10T16:30:00+00:00": 226.5850067138672,
      "2024-06-10T17:30:00+00:00": 227.39999389648438,
      "2024-06-10T18:30:00+00:00": 227.25999450683594,
      "2024-06-10T19:30:00+00:00": 226.27000427246094
    },
    "sentiment": 0.9044402241706848
  },
  {
    "title": "FDA Accepts Eisai's Filing of LEQEMBI\u00ae (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease",
    "published": 1717961467,
    "day_prices": {},
    "sentiment": 0.830771267414093
  },
  {
    "title": "Lilly's donanemab, remternetug set to dominate Alzheimer's treatment by 2030",
    "published": 1717899480,
    "day_prices": {},
    "sentiment": 0.7012604475021362
  },
  {
    "title": "Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP",
    "published": 1717784048,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 230.61000061035156,
      "2024-06-07T14:30:00+00:00": 227.8800048828125,
      "2024-06-07T15:30:00+00:00": 227.8300018310547,
      "2024-06-07T16:30:00+00:00": 226.97999572753906,
      "2024-06-07T17:30:00+00:00": 226.75999450683594,
      "2024-06-07T18:30:00+00:00": 226.4600067138672,
      "2024-06-07T19:30:00+00:00": 225.67999267578125
    },
    "sentiment": 0.4958362281322479
  },
  {
    "title": "Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?",
    "published": 1717774252,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 230.61000061035156,
      "2024-06-07T14:30:00+00:00": 227.8800048828125,
      "2024-06-07T15:30:00+00:00": 227.8300018310547,
      "2024-06-07T16:30:00+00:00": 226.97999572753906,
      "2024-06-07T17:30:00+00:00": 226.75999450683594,
      "2024-06-07T18:30:00+00:00": 226.4600067138672,
      "2024-06-07T19:30:00+00:00": 225.67999267578125
    },
    "sentiment": 0.9156343340873718
  },
  {
    "title": "(BIIB) - Analyzing Biogen's Short Interest",
    "published": 1717755600,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 230.61000061035156,
      "2024-06-07T14:30:00+00:00": 227.8800048828125,
      "2024-06-07T15:30:00+00:00": 227.8300018310547,
      "2024-06-07T16:30:00+00:00": 226.97999572753906,
      "2024-06-07T17:30:00+00:00": 226.75999450683594,
      "2024-06-07T18:30:00+00:00": 226.4600067138672,
      "2024-06-07T19:30:00+00:00": 225.67999267578125
    },
    "sentiment": 0.9379053711891174
  },
  {
    "title": "Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates",
    "published": 1717694940,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 235.1199951171875,
      "2024-06-06T14:30:00+00:00": 232.95460510253906,
      "2024-06-06T15:30:00+00:00": 232.5,
      "2024-06-06T16:30:00+00:00": 232.55999755859375,
      "2024-06-06T17:30:00+00:00": 233.5500030517578,
      "2024-06-06T18:30:00+00:00": 232.60499572753906,
      "2024-06-06T19:30:00+00:00": 232.83999633789062
    },
    "sentiment": 0.9425808787345886
  },
  {
    "title": "Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock",
    "published": 1717681810,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 235.1199951171875,
      "2024-06-06T14:30:00+00:00": 232.95460510253906,
      "2024-06-06T15:30:00+00:00": 232.5,
      "2024-06-06T16:30:00+00:00": 232.55999755859375,
      "2024-06-06T17:30:00+00:00": 233.5500030517578,
      "2024-06-06T18:30:00+00:00": 232.60499572753906,
      "2024-06-06T19:30:00+00:00": 232.83999633789062
    },
    "sentiment": 0.6101118922233582
  },
  {
    "title": "FDA suggests safety warning for Eli Lilly Alzheimer\u2019s drug",
    "published": 1717665120,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 235.1199951171875,
      "2024-06-06T14:30:00+00:00": 232.95460510253906,
      "2024-06-06T15:30:00+00:00": 232.5,
      "2024-06-06T16:30:00+00:00": 232.55999755859375,
      "2024-06-06T17:30:00+00:00": 233.5500030517578,
      "2024-06-06T18:30:00+00:00": 232.60499572753906,
      "2024-06-06T19:30:00+00:00": 232.83999633789062
    },
    "sentiment": 0.5038940906524658
  },
  {
    "title": "Novartis, Roche facing Italy antitrust probe over Lucentis biosimilar",
    "published": 1717654500,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 235.1199951171875,
      "2024-06-06T14:30:00+00:00": 232.95460510253906,
      "2024-06-06T15:30:00+00:00": 232.5,
      "2024-06-06T16:30:00+00:00": 232.55999755859375,
      "2024-06-06T17:30:00+00:00": 233.5500030517578,
      "2024-06-06T18:30:00+00:00": 232.60499572753906,
      "2024-06-06T19:30:00+00:00": 232.83999633789062
    },
    "sentiment": 0.933568000793457
  },
  {
    "title": "Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript",
    "published": 1717628047,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 234.4499969482422,
      "2024-06-05T14:30:00+00:00": 232.36000061035156,
      "2024-06-05T15:30:00+00:00": 233.7449951171875,
      "2024-06-05T16:30:00+00:00": 235.5,
      "2024-06-05T17:30:00+00:00": 236.33999633789062,
      "2024-06-05T18:30:00+00:00": 236.72999572753906,
      "2024-06-05T19:30:00+00:00": 236.58999633789062
    },
    "sentiment": 0.9119656085968018
  },
  {
    "title": "Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis",
    "published": 1717588346,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 234.4499969482422,
      "2024-06-05T14:30:00+00:00": 232.36000061035156,
      "2024-06-05T15:30:00+00:00": 233.7449951171875,
      "2024-06-05T16:30:00+00:00": 235.5,
      "2024-06-05T17:30:00+00:00": 236.33999633789062,
      "2024-06-05T18:30:00+00:00": 236.72999572753906,
      "2024-06-05T19:30:00+00:00": 236.58999633789062
    },
    "sentiment": 0.954596757888794
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Biogen (BIIB) and Axsome Therapeutics (AXSM)",
    "published": 1717566660,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 234.4499969482422,
      "2024-06-05T14:30:00+00:00": 232.36000061035156,
      "2024-06-05T15:30:00+00:00": 233.7449951171875,
      "2024-06-05T16:30:00+00:00": 235.5,
      "2024-06-05T17:30:00+00:00": 236.33999633789062,
      "2024-06-05T18:30:00+00:00": 236.72999572753906,
      "2024-06-05T19:30:00+00:00": 236.58999633789062
    },
    "sentiment": 0.9047881960868835
  },
  {
    "title": "Bullish Two Hundred Day Moving Average Cross - BIIB",
    "published": 1717557840,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 234.4499969482422,
      "2024-06-05T14:30:00+00:00": 232.36000061035156,
      "2024-06-05T15:30:00+00:00": 233.7449951171875,
      "2024-06-05T16:30:00+00:00": 235.5,
      "2024-06-05T17:30:00+00:00": 236.33999633789062,
      "2024-06-05T18:30:00+00:00": 236.72999572753906,
      "2024-06-05T19:30:00+00:00": 236.58999633789062
    },
    "sentiment": 0.8266980051994324
  },
  {
    "title": "Robbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class Action",
    "published": 1717453985,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 225.3000030517578,
      "2024-06-03T14:30:00+00:00": 231.11500549316406,
      "2024-06-03T15:30:00+00:00": 232.22500610351562,
      "2024-06-03T16:30:00+00:00": 228.06500244140625,
      "2024-06-03T17:30:00+00:00": 229.83999633789062,
      "2024-06-03T18:30:00+00:00": 230.44000244140625,
      "2024-06-03T19:30:00+00:00": 229.89999389648438
    },
    "sentiment": 0.9158973097801208
  },
  {
    "title": "Biogen, Delta Flight Products collaborate for accessible air travel",
    "published": 1717396500,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 225.3000030517578,
      "2024-06-03T14:30:00+00:00": 231.11500549316406,
      "2024-06-03T15:30:00+00:00": 232.22500610351562,
      "2024-06-03T16:30:00+00:00": 228.06500244140625,
      "2024-06-03T17:30:00+00:00": 229.83999633789062,
      "2024-06-03T18:30:00+00:00": 230.44000244140625,
      "2024-06-03T19:30:00+00:00": 229.89999389648438
    },
    "sentiment": 0.6533643007278442
  },
  {
    "title": "Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx\u2122 System for Administration of nusinersen",
    "published": 1722430800,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 212.0,
      "2024-07-31T14:30:00+00:00": 212.9499969482422,
      "2024-07-31T15:30:00+00:00": 215.32000732421875,
      "2024-07-31T16:30:00+00:00": 215.58999633789062,
      "2024-07-31T17:30:00+00:00": 216.72500610351562,
      "2024-07-31T18:30:00+00:00": 217.01499938964844,
      "2024-07-31T19:30:00+00:00": 214.9600067138672
    },
    "sentiment": 0.796604335308075
  },
  {
    "title": "Biogen Q2 2024 Earnings Preview",
    "published": 1722423840,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 212.0,
      "2024-07-31T14:30:00+00:00": 212.9499969482422,
      "2024-07-31T15:30:00+00:00": 215.32000732421875,
      "2024-07-31T16:30:00+00:00": 215.58999633789062,
      "2024-07-31T17:30:00+00:00": 216.72500610351562,
      "2024-07-31T18:30:00+00:00": 217.01499938964844,
      "2024-07-31T19:30:00+00:00": 214.9600067138672
    },
    "sentiment": 0.8341745138168335
  },
  {
    "title": "Vaccinex stock plunges 24% on mixed results for Alzheimer's study",
    "published": 1722420000,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 212.0,
      "2024-07-31T14:30:00+00:00": 212.9499969482422,
      "2024-07-31T15:30:00+00:00": 215.32000732421875,
      "2024-07-31T16:30:00+00:00": 215.58999633789062,
      "2024-07-31T17:30:00+00:00": 216.72500610351562,
      "2024-07-31T18:30:00+00:00": 217.01499938964844,
      "2024-07-31T19:30:00+00:00": 214.9600067138672
    },
    "sentiment": 0.9643994569778442
  },
  {
    "title": "Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx? System for Administration of nusinersen",
    "published": 1722416400,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 212.0,
      "2024-07-31T14:30:00+00:00": 212.9499969482422,
      "2024-07-31T15:30:00+00:00": 215.32000732421875,
      "2024-07-31T16:30:00+00:00": 215.58999633789062,
      "2024-07-31T17:30:00+00:00": 216.72500610351562,
      "2024-07-31T18:30:00+00:00": 217.01499938964844,
      "2024-07-31T19:30:00+00:00": 214.9600067138672
    },
    "sentiment": 0.8129990696907043
  },
  {
    "title": "New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI\u00ae (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer\u2019s Disease Patients Presented at The Alzheimer\u2019s Association International Conference (AAIC) 2024",
    "published": 1722374100,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.9498342275619507
  },
  {
    "title": "New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI? (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer?s Disease Patients Presented at The Alzheimer?s Association International Conference (AAIC) 2024",
    "published": 1722359700,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.9495929479598999
  },
  {
    "title": "New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI? (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at The Alzheimer's Association International Conference (AAIC) 2024",
    "published": 1722358800,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.9501595497131348
  },
  {
    "title": "Countdown to Biogen (BIIB) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS",
    "published": 1722345325,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.925897479057312
  },
  {
    "title": "Novo\u2019s older obesity drug benefits Alzheimer\u2019s patients in small trial",
    "published": 1722334020,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.837979257106781
  },
  {
    "title": "Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer?s Disease",
    "published": 1722324600,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.5605834722518921
  },
  {
    "title": "Biogen, Eisai present positive three-year use data for Leqembi",
    "published": 1722315900,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 214.2899932861328,
      "2024-07-30T14:30:00+00:00": 214.00999450683594,
      "2024-07-30T15:30:00+00:00": 212.6699981689453,
      "2024-07-30T16:30:00+00:00": 213.05999755859375,
      "2024-07-30T17:30:00+00:00": 212.1199951171875,
      "2024-07-30T18:30:00+00:00": 212.0,
      "2024-07-30T19:30:00+00:00": 211.86000061035156
    },
    "sentiment": 0.9334142804145813
  },
  {
    "title": "EU CHMP snubs Biogen and Eisai\u2019s Alzheimer\u2019s therapy Leqembi",
    "published": 1722273233,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 211.3300018310547,
      "2024-07-29T14:30:00+00:00": 213.8000030517578,
      "2024-07-29T15:30:00+00:00": 212.76739501953125,
      "2024-07-29T16:30:00+00:00": 212.52999877929688,
      "2024-07-29T17:30:00+00:00": 213.2899932861328,
      "2024-07-29T18:30:00+00:00": 215.13999938964844,
      "2024-07-29T19:30:00+00:00": 214.22000122070312
    },
    "sentiment": 0.8855848908424377
  },
  {
    "title": "3 Biotech Names With Potential Catalysts By Year End",
    "published": 1722267170,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 211.3300018310547,
      "2024-07-29T14:30:00+00:00": 213.8000030517578,
      "2024-07-29T15:30:00+00:00": 212.76739501953125,
      "2024-07-29T16:30:00+00:00": 212.52999877929688,
      "2024-07-29T17:30:00+00:00": 213.2899932861328,
      "2024-07-29T18:30:00+00:00": 215.13999938964844,
      "2024-07-29T19:30:00+00:00": 214.22000122070312
    },
    "sentiment": 0.5434496402740479
  },
  {
    "title": "Biogen price target lowered by $22 at Baird, here's why",
    "published": 1722236340,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 211.3300018310547,
      "2024-07-29T14:30:00+00:00": 213.8000030517578,
      "2024-07-29T15:30:00+00:00": 212.76739501953125,
      "2024-07-29T16:30:00+00:00": 212.52999877929688,
      "2024-07-29T17:30:00+00:00": 213.2899932861328,
      "2024-07-29T18:30:00+00:00": 215.13999938964844,
      "2024-07-29T19:30:00+00:00": 214.22000122070312
    },
    "sentiment": 0.8780532479286194
  },
  {
    "title": "Dr. Reddy's gets positive EMA opinion for rituximab biosimilar",
    "published": 1722216960,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 211.3300018310547,
      "2024-07-29T14:30:00+00:00": 213.8000030517578,
      "2024-07-29T15:30:00+00:00": 212.76739501953125,
      "2024-07-29T16:30:00+00:00": 212.52999877929688,
      "2024-07-29T17:30:00+00:00": 213.2899932861328,
      "2024-07-29T18:30:00+00:00": 215.13999938964844,
      "2024-07-29T19:30:00+00:00": 214.22000122070312
    },
    "sentiment": 0.939415454864502
  },
  {
    "title": "Alkermes: Fairly Valued After Post-Earnings Bump",
    "published": 1722146577,
    "day_prices": {},
    "sentiment": 0.5937658548355103
  },
  {
    "title": "NEW YORK MARKET CLOSE: Stocks fly, ending fraught week with a flourish",
    "published": 1722010680,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.6018935441970825
  },
  {
    "title": "EU Rejection of Alzheimer\u2019s Drug Is Another Disappointment for Biogen",
    "published": 1722005280,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.9588111639022827
  },
  {
    "title": "The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical",
    "published": 1722002460,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.9191737174987793
  },
  {
    "title": "Leqembi voted down by European regulators",
    "published": 1721993220,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.7976548075675964
  },
  {
    "title": "Buy Rating on Biogen: Anticipating Positive Reversal and Global Market Strength for Lecanemab",
    "published": 1721982360,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.9523976445198059
  },
  {
    "title": "TOP NEWS: Biogen's Alzheimer's treatment suffers setback in EU",
    "published": 1721980920,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.954124927520752
  },
  {
    "title": "Biogen-partnered Alzheimer\u2019s therapy fails to clear EU hurdle",
    "published": 1721975280,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 210.83729553222656,
      "2024-07-26T14:30:00+00:00": 213.10000610351562,
      "2024-07-26T15:30:00+00:00": 213.58999633789062,
      "2024-07-26T16:30:00+00:00": 214.39500427246094,
      "2024-07-26T17:30:00+00:00": 212.93499755859375,
      "2024-07-26T18:30:00+00:00": 211.7050018310547,
      "2024-07-26T19:30:00+00:00": 211.6199951171875
    },
    "sentiment": 0.8742020726203918
  },
  {
    "title": "Sage Therapeutics: Tremors Of Trouble, But PPD Progress (Rating Downgrade)",
    "published": 1721924703,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 227.1999969482422,
      "2024-07-25T14:30:00+00:00": 233.52000427246094,
      "2024-07-25T15:30:00+00:00": 231.5850067138672,
      "2024-07-25T16:30:00+00:00": 232.0500030517578,
      "2024-07-25T17:30:00+00:00": 231.49000549316406,
      "2024-07-25T18:30:00+00:00": 230.24000549316406,
      "2024-07-25T19:30:00+00:00": 229.66000366210938
    },
    "sentiment": 0.6945803761482239
  },
  {
    "title": "Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 for the Treatment of Essential Tremor",
    "published": 1721904635,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 227.1999969482422,
      "2024-07-25T14:30:00+00:00": 233.52000427246094,
      "2024-07-25T15:30:00+00:00": 231.5850067138672,
      "2024-07-25T16:30:00+00:00": 232.0500030517578,
      "2024-07-25T17:30:00+00:00": 231.49000549316406,
      "2024-07-25T18:30:00+00:00": 230.24000549316406,
      "2024-07-25T19:30:00+00:00": 229.66000366210938
    },
    "sentiment": 0.6037413477897644
  },
  {
    "title": "Sage Therapeutics cut to Neutral at J.P. Morgan on pipeline concerns",
    "published": 1721903520,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 227.1999969482422,
      "2024-07-25T14:30:00+00:00": 233.52000427246094,
      "2024-07-25T15:30:00+00:00": 231.5850067138672,
      "2024-07-25T16:30:00+00:00": 232.0500030517578,
      "2024-07-25T17:30:00+00:00": 231.49000549316406,
      "2024-07-25T18:30:00+00:00": 230.24000549316406,
      "2024-07-25T19:30:00+00:00": 229.66000366210938
    },
    "sentiment": 0.7588081955909729
  },
  {
    "title": "Sage and Biogen\u2019s SAGE-324 shows no benefit in essential tremor trial",
    "published": 1721897553,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 227.1999969482422,
      "2024-07-25T14:30:00+00:00": 233.52000427246094,
      "2024-07-25T15:30:00+00:00": 231.5850067138672,
      "2024-07-25T16:30:00+00:00": 232.0500030517578,
      "2024-07-25T17:30:00+00:00": 231.49000549316406,
      "2024-07-25T18:30:00+00:00": 230.24000549316406,
      "2024-07-25T19:30:00+00:00": 229.66000366210938
    },
    "sentiment": 0.6954528093338013
  },
  {
    "title": "Sage Therapeutics Stock Slides as Pipeline Thins",
    "published": 1721831640,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 224.10000610351562,
      "2024-07-24T14:30:00+00:00": 224.61000061035156,
      "2024-07-24T15:30:00+00:00": 225.7899932861328,
      "2024-07-24T16:30:00+00:00": 227.69500732421875,
      "2024-07-24T17:30:00+00:00": 226.91000366210938,
      "2024-07-24T18:30:00+00:00": 226.4499969482422,
      "2024-07-24T19:30:00+00:00": 226.3300018310547
    },
    "sentiment": 0.9693537354469299
  },
  {
    "title": "Biogen, Sage tremor drug fails key trial",
    "published": 1721823000,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 224.10000610351562,
      "2024-07-24T14:30:00+00:00": 224.61000061035156,
      "2024-07-24T15:30:00+00:00": 225.7899932861328,
      "2024-07-24T16:30:00+00:00": 227.69500732421875,
      "2024-07-24T17:30:00+00:00": 226.91000366210938,
      "2024-07-24T18:30:00+00:00": 226.4499969482422,
      "2024-07-24T19:30:00+00:00": 226.3300018310547
    },
    "sentiment": 0.7964563369750977
  },
  {
    "title": "Sage Therapeutics, Biogen report results from Phase 2 study of SAGE-324",
    "published": 1721815320,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 224.10000610351562,
      "2024-07-24T14:30:00+00:00": 224.61000061035156,
      "2024-07-24T15:30:00+00:00": 225.7899932861328,
      "2024-07-24T16:30:00+00:00": 227.69500732421875,
      "2024-07-24T17:30:00+00:00": 226.91000366210938,
      "2024-07-24T18:30:00+00:00": 226.4499969482422,
      "2024-07-24T19:30:00+00:00": 226.3300018310547
    },
    "sentiment": 0.9293995499610901
  },
  {
    "title": "Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails",
    "published": 1721797679,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 224.10000610351562,
      "2024-07-24T14:30:00+00:00": 224.61000061035156,
      "2024-07-24T15:30:00+00:00": 225.7899932861328,
      "2024-07-24T16:30:00+00:00": 227.69500732421875,
      "2024-07-24T17:30:00+00:00": 226.91000366210938,
      "2024-07-24T18:30:00+00:00": 226.4499969482422,
      "2024-07-24T19:30:00+00:00": 226.3300018310547
    },
    "sentiment": 0.9335864782333374
  },
  {
    "title": "Nanotechnology in medicine: Who are the leading public companies?",
    "published": 1721721144,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 225.08999633789062,
      "2024-07-23T14:30:00+00:00": 226.89500427246094,
      "2024-07-23T15:30:00+00:00": 226.6199951171875,
      "2024-07-23T16:30:00+00:00": 225.75,
      "2024-07-23T17:30:00+00:00": 225.72500610351562,
      "2024-07-23T18:30:00+00:00": 224.72300720214844,
      "2024-07-23T19:30:00+00:00": 224.1699981689453
    },
    "sentiment": 0.9433611631393433
  },
  {
    "title": "Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong",
    "published": 1721680040,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 227.72999572753906,
      "2024-07-22T14:30:00+00:00": 224.07000732421875,
      "2024-07-22T15:30:00+00:00": 226.38499450683594,
      "2024-07-22T16:30:00+00:00": 225.00999450683594,
      "2024-07-22T17:30:00+00:00": 225.48300170898438,
      "2024-07-22T18:30:00+00:00": 225.19000244140625,
      "2024-07-22T19:30:00+00:00": 224.99000549316406
    },
    "sentiment": 0.9259832501411438
  },
  {
    "title": "Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB",
    "published": 1721646968,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 227.72999572753906,
      "2024-07-22T14:30:00+00:00": 224.07000732421875,
      "2024-07-22T15:30:00+00:00": 226.38499450683594,
      "2024-07-22T16:30:00+00:00": 225.00999450683594,
      "2024-07-22T17:30:00+00:00": 225.48300170898438,
      "2024-07-22T18:30:00+00:00": 225.19000244140625,
      "2024-07-22T19:30:00+00:00": 224.99000549316406
    },
    "sentiment": 0.918032169342041
  },
  {
    "title": "Oppenheimer outlined a top buy and sell idea for each S&P sector",
    "published": 1721639220,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 227.72999572753906,
      "2024-07-22T14:30:00+00:00": 224.07000732421875,
      "2024-07-22T15:30:00+00:00": 226.38499450683594,
      "2024-07-22T16:30:00+00:00": 225.00999450683594,
      "2024-07-22T17:30:00+00:00": 225.48300170898438,
      "2024-07-22T18:30:00+00:00": 225.19000244140625,
      "2024-07-22T19:30:00+00:00": 224.99000549316406
    },
    "sentiment": 0.9024217128753662
  },
  {
    "title": "Sage Therapeutics/Biogen\u2019s episodic therapy zuranolone could change MDD treatment",
    "published": 1721625139,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 227.72999572753906,
      "2024-07-22T14:30:00+00:00": 224.07000732421875,
      "2024-07-22T15:30:00+00:00": 226.38499450683594,
      "2024-07-22T16:30:00+00:00": 225.00999450683594,
      "2024-07-22T17:30:00+00:00": 225.48300170898438,
      "2024-07-22T18:30:00+00:00": 225.19000244140625,
      "2024-07-22T19:30:00+00:00": 224.99000549316406
    },
    "sentiment": 0.5243546366691589
  },
  {
    "title": "Ionis (IONS) Completes Enrolment for Rare Disease Drug Study",
    "published": 1721397360,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 225.6699981689453,
      "2024-07-19T14:30:00+00:00": 225.1300048828125,
      "2024-07-19T15:30:00+00:00": 224.52999877929688,
      "2024-07-19T16:30:00+00:00": 225.6024932861328,
      "2024-07-19T17:30:00+00:00": 225.3000030517578,
      "2024-07-19T18:30:00+00:00": 224.58999633789062,
      "2024-07-19T19:30:00+00:00": 225.66000366210938
    },
    "sentiment": 0.7778841853141785
  },
  {
    "title": "Is Eli Lilly Stock A Sell On A Rare Stumble In Obesity Treatment?",
    "published": 1721321742,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 226.0,
      "2024-07-18T14:30:00+00:00": 229.80810546875,
      "2024-07-18T15:30:00+00:00": 229.39999389648438,
      "2024-07-18T16:30:00+00:00": 226.7100067138672,
      "2024-07-18T17:30:00+00:00": 226.55999755859375,
      "2024-07-18T18:30:00+00:00": 224.8800048828125,
      "2024-07-18T19:30:00+00:00": 225.39999389648438
    },
    "sentiment": 0.6505411863327026
  },
  {
    "title": "Patient Capital Management Q2 2024 Investment Review",
    "published": 1721306700,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 226.0,
      "2024-07-18T14:30:00+00:00": 229.80810546875,
      "2024-07-18T15:30:00+00:00": 229.39999389648438,
      "2024-07-18T16:30:00+00:00": 226.7100067138672,
      "2024-07-18T17:30:00+00:00": 226.55999755859375,
      "2024-07-18T18:30:00+00:00": 224.8800048828125,
      "2024-07-18T19:30:00+00:00": 225.39999389648438
    },
    "sentiment": 0.9441227316856384
  },
  {
    "title": "Levi & Korsinsky Notifies Shareholders of Biogen Inc.(BIIB) of a Class Action Lawsuit and an Upcoming Deadline",
    "published": 1721281583,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 226.0,
      "2024-07-18T14:30:00+00:00": 229.80810546875,
      "2024-07-18T15:30:00+00:00": 229.39999389648438,
      "2024-07-18T16:30:00+00:00": 226.7100067138672,
      "2024-07-18T17:30:00+00:00": 226.55999755859375,
      "2024-07-18T18:30:00+00:00": 224.8800048828125,
      "2024-07-18T19:30:00+00:00": 225.39999389648438
    },
    "sentiment": 0.8607268929481506
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH) and Biogen (BIIB)",
    "published": 1721211120,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 223.38999938964844,
      "2024-07-17T14:30:00+00:00": 227.3634033203125,
      "2024-07-17T15:30:00+00:00": 226.6699981689453,
      "2024-07-17T16:30:00+00:00": 227.15499877929688,
      "2024-07-17T17:30:00+00:00": 228.9499969482422,
      "2024-07-17T18:30:00+00:00": 229.30999755859375,
      "2024-07-17T19:30:00+00:00": 229.0500030517578
    },
    "sentiment": 0.48702317476272583
  },
  {
    "title": "The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIIB",
    "published": 1721195183,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 223.38999938964844,
      "2024-07-17T14:30:00+00:00": 227.3634033203125,
      "2024-07-17T15:30:00+00:00": 226.6699981689453,
      "2024-07-17T16:30:00+00:00": 227.15499877929688,
      "2024-07-17T17:30:00+00:00": 228.9499969482422,
      "2024-07-17T18:30:00+00:00": 229.30999755859375,
      "2024-07-17T19:30:00+00:00": 229.0500030517578
    },
    "sentiment": 0.7026382088661194
  },
  {
    "title": "Lexeo: Higher Dosing LX2006 Could Ignite FA Cardiomyopathy Program Further",
    "published": 1721135849,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 222.39500427246094,
      "2024-07-16T14:30:00+00:00": 225.24000549316406,
      "2024-07-16T15:30:00+00:00": 223.02999877929688,
      "2024-07-16T16:30:00+00:00": 223.60000610351562,
      "2024-07-16T17:30:00+00:00": 223.92999267578125,
      "2024-07-16T18:30:00+00:00": 224.85000610351562,
      "2024-07-16T19:30:00+00:00": 224.36000061035156
    },
    "sentiment": 0.9305192828178406
  },
  {
    "title": "Ionis Pharmaceuticals price target raised by $3 at BofA, here's why",
    "published": 1721095620,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 222.39500427246094,
      "2024-07-16T14:30:00+00:00": 225.24000549316406,
      "2024-07-16T15:30:00+00:00": 223.02999877929688,
      "2024-07-16T16:30:00+00:00": 223.60000610351562,
      "2024-07-16T17:30:00+00:00": 223.92999267578125,
      "2024-07-16T18:30:00+00:00": 224.85000610351562,
      "2024-07-16T19:30:00+00:00": 224.36000061035156
    },
    "sentiment": 0.6798871159553528
  },
  {
    "title": "Final Deadline Approaching for Biogen Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of July 22, 2024 Lead Plaintiff Deadline",
    "published": 1721035868,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 230.05999755859375,
      "2024-07-15T14:30:00+00:00": 225.9550018310547,
      "2024-07-15T15:30:00+00:00": 225.7050018310547,
      "2024-07-15T16:30:00+00:00": 225.57000732421875,
      "2024-07-15T17:30:00+00:00": 223.3000030517578,
      "2024-07-15T18:30:00+00:00": 223.4199981689453,
      "2024-07-15T19:30:00+00:00": 222.2100067138672
    },
    "sentiment": 0.9472546577453613
  },
  {
    "title": "Larimar Therapeutics: More Data Still Needed",
    "published": 1721015985,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 230.05999755859375,
      "2024-07-15T14:30:00+00:00": 225.9550018310547,
      "2024-07-15T15:30:00+00:00": 225.7050018310547,
      "2024-07-15T16:30:00+00:00": 225.57000732421875,
      "2024-07-15T17:30:00+00:00": 223.3000030517578,
      "2024-07-15T18:30:00+00:00": 223.4199981689453,
      "2024-07-15T19:30:00+00:00": 222.2100067138672
    },
    "sentiment": 0.9230761528015137
  },
  {
    "title": "Eli Lilly Overcomes Biden-Tied Stumble To Rise Again \u2014 Is Lilly Stock Now A Buy?",
    "published": 1720785642,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 237.97999572753906,
      "2024-07-12T14:30:00+00:00": 232.61000061035156,
      "2024-07-12T15:30:00+00:00": 231.9600067138672,
      "2024-07-12T16:30:00+00:00": 227.9550018310547,
      "2024-07-12T17:30:00+00:00": 227.30499267578125,
      "2024-07-12T18:30:00+00:00": 228.75,
      "2024-07-12T19:30:00+00:00": 229.58999633789062
    },
    "sentiment": 0.7199409008026123
  },
  {
    "title": "Biogen Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIIB",
    "published": 1720763178,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 237.97999572753906,
      "2024-07-12T14:30:00+00:00": 232.61000061035156,
      "2024-07-12T15:30:00+00:00": 231.9600067138672,
      "2024-07-12T16:30:00+00:00": 227.9550018310547,
      "2024-07-12T17:30:00+00:00": 227.30499267578125,
      "2024-07-12T18:30:00+00:00": 228.75,
      "2024-07-12T19:30:00+00:00": 229.58999633789062
    },
    "sentiment": 0.8530596494674683
  },
  {
    "title": "BIIB Investors Have Opportunity to Join Biogen Inc. Securities Fraud Investigation with the Schall Law Firm",
    "published": 1720695066,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 234.5,
      "2024-07-11T14:30:00+00:00": 237.0399932861328,
      "2024-07-11T15:30:00+00:00": 236.61000061035156,
      "2024-07-11T16:30:00+00:00": 236.02000427246094,
      "2024-07-11T17:30:00+00:00": 236.38999938964844,
      "2024-07-11T18:30:00+00:00": 236.19000244140625,
      "2024-07-11T19:30:00+00:00": 235.8699951171875
    },
    "sentiment": 0.7702834010124207
  },
  {
    "title": "3 Highly Rated Biotech Stocks for Your July Buy List",
    "published": 1720174800,
    "day_prices": {
      "2024-07-05T13:30:00+00:00": 225.02999877929688,
      "2024-07-05T14:30:00+00:00": 223.80520629882812,
      "2024-07-05T15:30:00+00:00": 224.8699951171875,
      "2024-07-05T16:30:00+00:00": 225.46499633789062,
      "2024-07-05T17:30:00+00:00": 225.4499969482422,
      "2024-07-05T18:30:00+00:00": 225.83999633789062,
      "2024-07-05T19:30:00+00:00": 225.64500427246094
    },
    "sentiment": 0.9089598059654236
  },
  {
    "title": "Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More",
    "published": 1720024668,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 229.4499969482422,
      "2024-07-03T14:30:00+00:00": 225.5850067138672,
      "2024-07-03T15:30:00+00:00": 223.75999450683594
    },
    "sentiment": 0.9138810038566589
  },
  {
    "title": "Biden Just Knocked Eli Lilly Stock Off Its Pedestal \u2014 Is It A Buy Or A Sell?",
    "published": 1720008042,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 229.4499969482422,
      "2024-07-03T14:30:00+00:00": 225.5850067138672,
      "2024-07-03T15:30:00+00:00": 223.75999450683594
    },
    "sentiment": 0.856859564781189
  },
  {
    "title": "Eli Lilly Advances Alzheimer's Solutions With Kisunla Approval",
    "published": 1719989544,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 229.4499969482422,
      "2024-07-03T14:30:00+00:00": 225.5850067138672,
      "2024-07-03T15:30:00+00:00": 223.75999450683594
    },
    "sentiment": 0.696601390838623
  },
  {
    "title": "Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug",
    "published": 1719951222,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 232.02499389648438,
      "2024-07-02T14:30:00+00:00": 229.85499572753906,
      "2024-07-02T15:30:00+00:00": 229.72000122070312,
      "2024-07-02T16:30:00+00:00": 228.88999938964844,
      "2024-07-02T17:30:00+00:00": 228.22999572753906,
      "2024-07-02T18:30:00+00:00": 228.36000061035156,
      "2024-07-02T19:30:00+00:00": 228.67999267578125
    },
    "sentiment": 0.8460701704025269
  },
  {
    "title": "Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai",
    "published": 1719944202,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 232.02499389648438,
      "2024-07-02T14:30:00+00:00": 229.85499572753906,
      "2024-07-02T15:30:00+00:00": 229.72000122070312,
      "2024-07-02T16:30:00+00:00": 228.88999938964844,
      "2024-07-02T17:30:00+00:00": 228.22999572753906,
      "2024-07-02T18:30:00+00:00": 228.36000061035156,
      "2024-07-02T19:30:00+00:00": 228.67999267578125
    },
    "sentiment": 0.8514594435691833
  },
  {
    "title": "Biogen Completes Acquisition of Human Immunology Biosciences",
    "published": 1719926160,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 232.02499389648438,
      "2024-07-02T14:30:00+00:00": 229.85499572753906,
      "2024-07-02T15:30:00+00:00": 229.72000122070312,
      "2024-07-02T16:30:00+00:00": 228.88999938964844,
      "2024-07-02T17:30:00+00:00": 228.22999572753906,
      "2024-07-02T18:30:00+00:00": 228.36000061035156,
      "2024-07-02T19:30:00+00:00": 228.67999267578125
    },
    "sentiment": 0.8426946997642517
  },
  {
    "title": "10 clinical trials to watch in the second half of 2024",
    "published": 1719810000,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 231.41000366210938,
      "2024-07-01T14:30:00+00:00": 232.33999633789062,
      "2024-07-01T15:30:00+00:00": 232.69000244140625,
      "2024-07-01T16:30:00+00:00": 231.22500610351562,
      "2024-07-01T17:30:00+00:00": 231.60000610351562,
      "2024-07-01T18:30:00+00:00": 231.6649932861328,
      "2024-07-01T19:30:00+00:00": 231.67999267578125
    },
    "sentiment": 0.9099512696266174
  },
  {
    "title": "Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker",
    "published": 1724815440,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 203.75999450683594,
      "2024-08-28T14:30:00+00:00": 204.18499755859375,
      "2024-08-28T15:30:00+00:00": 203.9600067138672,
      "2024-08-28T16:30:00+00:00": 203.97000122070312,
      "2024-08-28T17:30:00+00:00": 204.0050048828125,
      "2024-08-28T18:30:00+00:00": 203.49000549316406,
      "2024-08-28T19:30:00+00:00": 204.47000122070312
    },
    "sentiment": 0.7023048400878906
  },
  {
    "title": "Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety",
    "published": 1724658480,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 206.22999572753906,
      "2024-08-26T14:30:00+00:00": 205.57269287109375,
      "2024-08-26T15:30:00+00:00": 204.3300018310547,
      "2024-08-26T16:30:00+00:00": 205.15499877929688,
      "2024-08-26T17:30:00+00:00": 205.27999877929688,
      "2024-08-26T18:30:00+00:00": 204.72000122070312,
      "2024-08-26T19:30:00+00:00": 205.0500030517578
    },
    "sentiment": 0.95933997631073
  },
  {
    "title": "Eli Lilly Alzheimer\u2019s drug set to face same fate as Biogen\u2019s in U.K.: report",
    "published": 1724502060,
    "day_prices": {},
    "sentiment": 0.8033482432365417
  },
  {
    "title": "Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement",
    "published": 1724348750,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.6124367117881775
  },
  {
    "title": "Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term",
    "published": 1724334007,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.8755196928977966
  },
  {
    "title": "UK approves Leqembi, but reimbursement may not follow",
    "published": 1724326680,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.8678172826766968
  },
  {
    "title": "Leqembi\u00ae (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain",
    "published": 1724317800,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.7313514351844788
  },
  {
    "title": "Alzheimer's drug approved in U.K., too costly for NHS, FT reports",
    "published": 1724316420,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.6662265658378601
  },
  {
    "title": "Biogen Alzheimer's treatment gets the nod in UK, but cost a hurdle",
    "published": 1724305920,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.8487858176231384
  },
  {
    "title": "UK patients unlikely to get access to Eisai-Biogen's Alzheimer's drug",
    "published": 1724302984,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 206.75999450683594,
      "2024-08-22T14:30:00+00:00": 203.77000427246094,
      "2024-08-22T15:30:00+00:00": 203.82000732421875,
      "2024-08-22T16:30:00+00:00": 202.6999969482422,
      "2024-08-22T17:30:00+00:00": 201.83999633789062,
      "2024-08-22T18:30:00+00:00": 202.0399932861328,
      "2024-08-22T19:30:00+00:00": 202.17999267578125
    },
    "sentiment": 0.7055610418319702
  },
  {
    "title": "Denali Therapeutics Continues To Have Plenty Of Moving Parts",
    "published": 1724167996,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 205.38999938964844,
      "2024-08-20T14:30:00+00:00": 206.38999938964844,
      "2024-08-20T15:30:00+00:00": 205.42999267578125,
      "2024-08-20T16:30:00+00:00": 206.18589782714844,
      "2024-08-20T17:30:00+00:00": 206.44500732421875,
      "2024-08-20T18:30:00+00:00": 206.4600067138672,
      "2024-08-20T19:30:00+00:00": 205.7899932861328
    },
    "sentiment": 0.5219765305519104
  },
  {
    "title": "Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology",
    "published": 1724108159,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 202.47000122070312,
      "2024-08-19T14:30:00+00:00": 205.5,
      "2024-08-19T15:30:00+00:00": 206.13499450683594,
      "2024-08-19T16:30:00+00:00": 205.02000427246094,
      "2024-08-19T17:30:00+00:00": 205.22000122070312,
      "2024-08-19T18:30:00+00:00": 205.3699951171875,
      "2024-08-19T19:30:00+00:00": 205.32000732421875
    },
    "sentiment": 0.7811194062232971
  },
  {
    "title": "Optimistic Outlook for Biogen\u2019s Dapirolizumab Pegol Despite Past Setbacks",
    "published": 1724040960,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 202.47000122070312,
      "2024-08-19T14:30:00+00:00": 205.5,
      "2024-08-19T15:30:00+00:00": 206.13499450683594,
      "2024-08-19T16:30:00+00:00": 205.02000427246094,
      "2024-08-19T17:30:00+00:00": 205.22000122070312,
      "2024-08-19T18:30:00+00:00": 205.3699951171875,
      "2024-08-19T19:30:00+00:00": 205.32000732421875
    },
    "sentiment": 0.948575496673584
  },
  {
    "title": "First Week of April 2025 Options Trading For Biogen (BIIB)",
    "published": 1723801920,
    "day_prices": {
      "2024-08-16T13:30:00+00:00": 201.99000549316406,
      "2024-08-16T14:30:00+00:00": 201.46449279785156,
      "2024-08-16T15:30:00+00:00": 202.33999633789062,
      "2024-08-16T16:30:00+00:00": 202.0399932861328,
      "2024-08-16T17:30:00+00:00": 203.125,
      "2024-08-16T18:30:00+00:00": 202.8699951171875,
      "2024-08-16T19:30:00+00:00": 202.76499938964844
    },
    "sentiment": 0.9499061703681946
  },
  {
    "title": "IN BRIEF: Biogen's Leqembi approved to treat Alzheimer's in the UAE",
    "published": 1723650420,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 203.74000549316406,
      "2024-08-14T14:30:00+00:00": 202.1002960205078,
      "2024-08-14T15:30:00+00:00": 201.88999938964844,
      "2024-08-14T16:30:00+00:00": 201.2100067138672,
      "2024-08-14T17:30:00+00:00": 200.53280639648438,
      "2024-08-14T18:30:00+00:00": 200.6300048828125,
      "2024-08-14T19:30:00+00:00": 200.89920043945312
    },
    "sentiment": 0.7284848690032959
  },
  {
    "title": "Invesco Main Street Fund Q2 2024 Review",
    "published": 1723630500,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 203.74000549316406,
      "2024-08-14T14:30:00+00:00": 202.1002960205078,
      "2024-08-14T15:30:00+00:00": 201.88999938964844,
      "2024-08-14T16:30:00+00:00": 201.2100067138672,
      "2024-08-14T17:30:00+00:00": 200.53280639648438,
      "2024-08-14T18:30:00+00:00": 200.6300048828125,
      "2024-08-14T19:30:00+00:00": 200.89920043945312
    },
    "sentiment": 0.9516288042068481
  },
  {
    "title": "Biogen Enhances Financial Flexibility with New Credit Facility",
    "published": 1723607940,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 203.74000549316406,
      "2024-08-14T14:30:00+00:00": 202.1002960205078,
      "2024-08-14T15:30:00+00:00": 201.88999938964844,
      "2024-08-14T16:30:00+00:00": 201.2100067138672,
      "2024-08-14T17:30:00+00:00": 200.53280639648438,
      "2024-08-14T18:30:00+00:00": 200.6300048828125,
      "2024-08-14T19:30:00+00:00": 200.89920043945312
    },
    "sentiment": 0.9502466320991516
  },
  {
    "title": "Eli Lilly Q2 Earnings: Thanks To Tirzepatide, $1 Trillion Valuation Now In Sight",
    "published": 1723465109,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 202.0,
      "2024-08-12T14:30:00+00:00": 202.5,
      "2024-08-12T15:30:00+00:00": 201.1999969482422,
      "2024-08-12T16:30:00+00:00": 200.47000122070312,
      "2024-08-12T17:30:00+00:00": 200.89669799804688,
      "2024-08-12T18:30:00+00:00": 200.14500427246094,
      "2024-08-12T19:30:00+00:00": 200.19500732421875
    },
    "sentiment": 0.9018388986587524
  },
  {
    "title": "A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.",
    "published": 1723381500,
    "day_prices": {},
    "sentiment": 0.6471796035766602
  },
  {
    "title": "Ionis Pharmaceuticals: Harnessing RNA-Targeted Therapies For Long-Term Shareholder Value",
    "published": 1723359060,
    "day_prices": {},
    "sentiment": 0.6314120888710022
  },
  {
    "title": "How Is The Market Feeling About Biogen?",
    "published": 1723171560,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 203.1199951171875,
      "2024-08-09T14:30:00+00:00": 201.85499572753906,
      "2024-08-09T15:30:00+00:00": 201.83999633789062,
      "2024-08-09T16:30:00+00:00": 201.22999572753906,
      "2024-08-09T17:30:00+00:00": 202.47999572753906,
      "2024-08-09T18:30:00+00:00": 202.2899932861328,
      "2024-08-09T19:30:00+00:00": 202.0399932861328
    },
    "sentiment": 0.8888881206512451
  },
  {
    "title": "September 27th Options Now Available For Biogen (BIIB)",
    "published": 1723112280,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 199.8300018310547,
      "2024-08-08T14:30:00+00:00": 201.28500366210938,
      "2024-08-08T15:30:00+00:00": 201.1300048828125,
      "2024-08-08T16:30:00+00:00": 202.58999633789062,
      "2024-08-08T17:30:00+00:00": 202.48500061035156,
      "2024-08-08T18:30:00+00:00": 202.86000061035156,
      "2024-08-08T19:30:00+00:00": 202.18499755859375
    },
    "sentiment": 0.9387626051902771
  },
  {
    "title": "Biogen price target lowered by $10 at Canaccord, here's why",
    "published": 1722929520,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 198.75999450683594,
      "2024-08-06T14:30:00+00:00": 201.1750030517578,
      "2024-08-06T15:30:00+00:00": 200.66000366210938,
      "2024-08-06T16:30:00+00:00": 201.6750030517578,
      "2024-08-06T17:30:00+00:00": 200.8948974609375,
      "2024-08-06T18:30:00+00:00": 202.64999389648438,
      "2024-08-06T19:30:00+00:00": 201.02000427246094
    },
    "sentiment": 0.797338604927063
  },
  {
    "title": "Results: Biogen Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts",
    "published": 1722882774,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 203.8350067138672,
      "2024-08-05T14:30:00+00:00": 198.97000122070312,
      "2024-08-05T15:30:00+00:00": 200.97999572753906,
      "2024-08-05T16:30:00+00:00": 200.4199981689453,
      "2024-08-05T17:30:00+00:00": 198.85000610351562,
      "2024-08-05T18:30:00+00:00": 198.27000427246094,
      "2024-08-05T19:30:00+00:00": 198.22000122070312
    },
    "sentiment": 0.9523324370384216
  },
  {
    "title": "GLOBAL BROKER RATINGS: RBC cuts Moderna; Stifel likes Interpump",
    "published": 1722842760,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 203.8350067138672,
      "2024-08-05T14:30:00+00:00": 198.97000122070312,
      "2024-08-05T15:30:00+00:00": 200.97999572753906,
      "2024-08-05T16:30:00+00:00": 200.4199981689453,
      "2024-08-05T17:30:00+00:00": 198.85000610351562,
      "2024-08-05T18:30:00+00:00": 198.27000427246094,
      "2024-08-05T19:30:00+00:00": 198.22000122070312
    },
    "sentiment": 0.4504307508468628
  },
  {
    "title": "Buy Rating Affirmed for Biogen Amid Strong Core Performance and Strategic Growth Initiatives",
    "published": 1722820860,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 203.8350067138672,
      "2024-08-05T14:30:00+00:00": 198.97000122070312,
      "2024-08-05T15:30:00+00:00": 200.97999572753906,
      "2024-08-05T16:30:00+00:00": 200.4199981689453,
      "2024-08-05T17:30:00+00:00": 198.85000610351562,
      "2024-08-05T18:30:00+00:00": 198.27000427246094,
      "2024-08-05T19:30:00+00:00": 198.22000122070312
    },
    "sentiment": 0.9521369934082031
  },
  {
    "title": "Oppenheimer Reaffirms Their Buy Rating on Biogen (BIIB)",
    "published": 1722583860,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.8345330953598022
  },
  {
    "title": "Biogen price target raised by $10 at RBC Capital, here's why",
    "published": 1722582720,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.7696227431297302
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Altimmune (ALT), Exact Sciences (EXAS)",
    "published": 1722580500,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.5922756791114807
  },
  {
    "title": "RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)",
    "published": 1722577320,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.49897974729537964
  },
  {
    "title": "Biogen price target lowered by $10 at Barclays, here's why",
    "published": 1722574560,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.8223384022712708
  },
  {
    "title": "Biogen Inc (BIIB) Q2 2024 Earnings Call Transcript Highlights: Strong Product Launches and Cost ...",
    "published": 1722560760,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 212.4499969482422,
      "2024-08-02T14:30:00+00:00": 205.75,
      "2024-08-02T15:30:00+00:00": 203.30999755859375,
      "2024-08-02T16:30:00+00:00": 205.97999572753906,
      "2024-08-02T17:30:00+00:00": 205.42999267578125,
      "2024-08-02T18:30:00+00:00": 205.6699981689453,
      "2024-08-02T19:30:00+00:00": 205.19000244140625
    },
    "sentiment": 0.9389796853065491
  },
  {
    "title": "Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback",
    "published": 1722530820,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.8533642292022705
  },
  {
    "title": "NEW YORK MARKET CLOSE: Stocks suffer as economic nerves spark sell-off",
    "published": 1722528960,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9696229696273804
  },
  {
    "title": "Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise",
    "published": 1722526020,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.5875685811042786
  },
  {
    "title": "Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat",
    "published": 1722524573,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9550237655639648
  },
  {
    "title": "Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "published": 1722519030,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.8990895748138428
  },
  {
    "title": "US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?",
    "published": 1722514500,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9108864068984985
  },
  {
    "title": "Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates",
    "published": 1722513907,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.6738596558570862
  },
  {
    "title": "Biogen boosts profit outlook on \u2018momentum\u2019 for new drugs, but stock dips",
    "published": 1722509280,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9056105613708496
  },
  {
    "title": "Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx System for Administration of nusinersen",
    "published": 1722504766,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.8328083753585815
  },
  {
    "title": "Buy Rating Affirmed for Biogen: Strong Financials and Promising Alzheimer\u2019s Drugs Drive Growth Outlook",
    "published": 1722501420,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9511468410491943
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Cencora (COR), Schrodinger (SDGR) and Biogen (BIIB)",
    "published": 1722500100,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.7385167479515076
  },
  {
    "title": "Biogen\u2019s Strong Q2 Performance and Promising Outlook Justify Buy Rating",
    "published": 1722499860,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9299951195716858
  },
  {
    "title": "Biogen posts Q2 beat as sales from Alzheimer\u2019s drug picks up",
    "published": 1722498660,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9429130554199219
  },
  {
    "title": "Strong Q2 Performance and Raised Guidance Secure Biogen a Buy Rating",
    "published": 1722496980,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9534943699836731
  },
  {
    "title": "Biogen Non-GAAP EPS of $4.02 misses by $0.01, revenue of $2.46B beats by $70M",
    "published": 1722492840,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.5400402545928955
  },
  {
    "title": "Biogen raises FY24 EPS view to $15.75-$16.25, consensus $15.58",
    "published": 1722491580,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.8069916367530823
  },
  {
    "title": "BIIB September 13th Options Begin Trading",
    "published": 1722485580,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 215.8000030517578,
      "2024-08-01T14:30:00+00:00": 206.5800018310547,
      "2024-08-01T15:30:00+00:00": 208.88499450683594,
      "2024-08-01T16:30:00+00:00": 206.86000061035156,
      "2024-08-01T17:30:00+00:00": 207.22999572753906,
      "2024-08-01T18:30:00+00:00": 207.3249969482422,
      "2024-08-01T19:30:00+00:00": 208.38999938964844
    },
    "sentiment": 0.9418317079544067
  }
]